Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes

ClinicalTrials.gov ID: NCT02152371

Public ClinicalTrials.gov record NCT02152371. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 3:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind Trial Comparing the Effect of Dulaglutide 1.5 mg With Placebo on Glycemic Control in Patients With Type 2 Diabetes on Basal Insulin Glargine

Study identification

NCT ID
NCT02152371
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
300 participants

Conditions and interventions

Interventions

  • Dulaglutide Drug
  • Insulin Glargine Drug
  • Metformin Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2014
Primary completion
Sep 30, 2015
Completion
Sep 30, 2015
Last update posted
Sep 24, 2019

2014 – 2015

United States locations

U.S. sites
13
U.S. states
10
U.S. cities
13
Facility City State ZIP Site status
Valley Endocrine, Fresno Fresno California 93720
Mills-Peninsula Diabetes Research Insitute San Mateo California 94401
University Clinical Investigators, Inc. Tustin California 92780
Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls Idaho 83404
Northwest Endo Diabetes Research, LLC Arlington Heights Illinois 60005
Cotton O'Neil Clinic Topeka Kansas 66606
Kentucky Diabetes Endocrinology Center Lexington Kentucky 40503
AB Clinical Trials Las Vegas Nevada 89119
SHS Clinical Research Group Toms River New Jersey 08753
Bland Clinic, PA Greensboro North Carolina 27401
PMG Research of Knoxville Knoxville Tennessee 37912
Rainier Clinical Research Center Renton Washington 98057
Polyclinic Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02152371, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 24, 2019 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02152371 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →